GlassScriptPhysician profile
Marshall A Beckman
NPI 1063520963
$12,988.71
in general payments reported to CMS, 2019-2025
14 companies · $672 in 2025
The $672 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,455 · 2020: $243 · 2021: $9,564 · 2022: $152 · 2023: $115 · 2024: $787 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $931 · Travel and Lodging: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $931.24 |
| Travel and Lodging | $643.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,489.55 | 2021-2024 | Da Vinci Surgical System |
| Stryker Corporation | $1,410.21 | 2019 | |
| Zimmer Biomet Holdings, INC. | $1,035.03 | 2021 | |
| Boston Scientific Corporation | $382.75 | 2020-2025 | Axios |
| Polynovo North America LLC | $219.79 | 2025 | Novosorb Btm |
| Prytime Medical Devices, INC. | $174.36 | 2020 | |
| Solventum Corporation | $68.73 | 2025 | V.A.C. Veraflo |
| Integra Lifesciences Corporation | $62.56 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Conmed Corporation | $61.55 | 2023-2025 | Airseal |
| Ethicon US, LLC | $20.97 | 2020 | |
| Medline Industries LP | $18.70 | 2019 | |
| Kci USA, INC. | $18.41 | 2020 | |
| Acell, INC. | $16.27 | 2019 | |
| Kls-Martin L.P. | $9.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Beckman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.